Camosunate Adult Tablet 300mg/100mg x12

Camosunate Adult Tablet 300mg/100mg is a potent antimalarial medication combining Artesunate (300mg) and Amodiaquine (100mg). This artemisinin-based combination therapy (ACT) is designed to effectively treat acute uncomplicated malaria caused by Plasmodium falciparum, including multi-drug resistant strains.

Uses

Camosunate Adult Tablet is primarily used for the treatment of acute uncomplicated malaria in adults and children weighing 36kg or more. It’s particularly effective against Plasmodium falciparum malaria, including cases resistant to other antimalarial drugs. This medication is not intended for malaria prevention.

Benefits

• Rapid and effective treatment of acute uncomplicated malaria
• Combines two potent antimalarial agents for enhanced efficacy
• Effective against drug-resistant strains of P. falciparum
• Reduces the risk of severe malaria complications
• Helps prevent the spread of malaria in endemic areas
• Contributes to global efforts in malaria control and elimination

How It Works

Artesunate, a fast-acting artemisinin derivative, rapidly reduces parasite load by targeting the early stages of parasite development. Amodiaquine, a longer-acting drug, eliminates remaining parasites and provides extended protection against recurrence. This combination approach ensures comprehensive treatment and helps prevent the development of drug resistance.

Dosage

The typical adult dosage is two tablet of Camosunate Adult (300mg Artesunate/100mg Amodiaquine) twice daily for three consecutive days. Take the tablet with water, preferably at the same time each day. Complete the full course of treatment even if symptoms improve before the course is finished.

Side Effects

Common side effects may include nausea, vomiting, abdominal pain, diarrhea, headache, dizziness, and fatigue. Most side effects are mild and resolve on their own. However, if you experience severe or persistent side effects, seek medical attention immediately.

Warning

Camosunate Adult should not be used in patients with known hypersensitivity to artesunate or amodiaquine. It’s not recommended for severe malaria or malaria prophylaxis. Patients with a history of liver or blood disorders should use this medication with caution and under close medical supervision.

Pregnancy and Breastfeeding

Pregnant women should use Camosunate Adult only if clearly necessary and under direct medical supervision. The benefits of treating malaria during pregnancy usually outweigh the potential risks. Breastfeeding mothers should consult their healthcare provider before using this medication.

Interaction

• May interact with drugs metabolized by CYP2C8 enzymes
• Potential interaction with drugs that prolong the QT interval
• May affect the efficacy of live typhoid vaccine
• Could interact with certain antiretroviral medications
• Possible interaction with some antidepressants and antipsychotics

Important Information

Before taking Camosunate Adult, inform your healthcare provider about any medical conditions, especially liver or heart problems, and all medications you’re currently taking. Complete the full course of treatment to ensure effective parasite clearance and reduce the risk of recurrence or drug resistance. If symptoms persist or worsen after treatment, seek immediate medical attention.